Ibaraki, Japan

Yoshifumi Ikejiri


Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 105(Granted Patents)


Company Filing History:


Years Active: 1995-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Inventor Yoshifumi Ikejiri

Introduction:

Yoshifumi Ikejiri, a talented inventor hailing from Ibaraki, Japan, has made a significant mark in the field of pharmaceutical compositions with his innovative creations. Holding a total of four patents, Ikejiri's contributions have been particularly impactful in the treatment of glaucoma.

Latest Patents:

Among his recent patents is a groundbreaking Pharmaceutical Composition for use in glaucoma treatment. This composition for eye drops features 3,4-dihydro-2,8-diisopropyl-3-thioxo-2H-1,4-benzoxadine-4-acetic acid or a pharmaceutically acceptable salt thereof, combined with cyclodextrin to enhance its efficacy.

Career Highlights:

Throughout his career, Ikejiri has been associated with renowned companies such as Senju Pharmaceutical Co., Ltd., where his passion for innovation and pharmaceuticals truly flourished. His relentless pursuit of excellence has led to the development of pioneering solutions for ocular health.

Collaborations:

In his professional journey, Ikejiri has had the privilege of collaborating with esteemed individuals in the industry, including Takahiro Ogawa and Fuminori Tokumochi. Together, they have pushed the boundaries of traditional medicine and introduced novel concepts that have reshaped the landscape of glaucoma treatment.

Conclusion:

Yoshifumi Ikejiri's commitment to innovation and his relentless quest for creating impactful pharmaceutical compositions have cemented his legacy as a visionary inventor in the field of ocular health. His contributions continue to inspire and pave the way for future advancements in the realm of glaucoma treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…